Atypical presentation and severity of Dengue fever in patients with CKD [0.03%]
慢性肾脏病患者登革热的不典型表现及严重程度
Mamitiana Randriamanana,Yves-Marie Diarra,Antoine Bertolotti et al.
Mamitiana Randriamanana et al.
Background and hypothesis: Dengue fever and chronic kidney disease (CKD) are growing health concerns. However, the features and indicators of severe dengue (SD) in CKD patients remain poorly understood. This study aimed t...
Evidence-Based Medicine versus Personalized Medicine when attempting to block complement in IgA nephropathy [0.03%]
基于证据的医学与个性化医学在IgA肾病中阻断补体方面的区别
Giuseppe Castellano,Matteo Stravalaci,Manuel A Podestà et al.
Giuseppe Castellano et al.
Impact of immunosuppressive therapy on renal and patient survival in rapidly progressive secondary IgA nephropathy [0.03%]
免疫抑制疗法对快速进展性继发性IgA肾病患者生存率和肾脏存活率的影响
Amir Shabaka,Ángel M Sevillano,Javier Vian et al.
Amir Shabaka et al.
Background: Secondary IgA nephropathy (IgAN) associated with systemic diseases represents a heterogeneous population in whom renal prognosis and treatment response are poorly defined. Patients with secondary IgAN have bee...
Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability [0.03%]
严重的妊娠相关急性肾损伤与产妇脆弱性
Hung-Wei Liao,Valerie Luyckx,Marlies Ostermann et al.
Hung-Wei Liao et al.
Background: Severe pregnancy-associated acute kidney injury (PrAKI) is an uncommon but life-threatening complication of pregnancy. Contemporary population-level data on severe PrAKI in high-income countries, and the impac...
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate [0.03%]
司美格鲁肽对肾小球滤过率测定值与估算值影响的差异
Rafal Yahya,Esben Iversen,Suvanjaa Sivalingam et al.
Rafal Yahya et al.
Background and hypothesis: Semaglutide is a glucagon-like peptide-1 receptor agonist widely used for its glucose-lowering effects in people with type 2 diabetes (T2D), as well as its cardiovascular and kidney-protective p...
Beyond Diffusion and Convection: Is Adsorption the Third Dimension of Dialysis? [0.03%]
吸附是透析的第三维度吗?
Paolo Lentini,Kianoush Kashani
Paolo Lentini
Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties [0.03%]
补体三级(C3)肾小球病的关键临床试验:已解答和未解决的问题
Fernando Caravaca-Fontan,Annette Bruchfeld,Sarah M Moran et al.
Fernando Caravaca-Fontan et al.
Complement 3 glomerulopathy (C3G) and primary immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) are ultra-rare glomerular diseases driven by dysregulation of the complement system, most commonly involving the altern...
Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease [0.03%]
慢性肾脏病患者尿蛋白与白蛋白作为评估肾衰风险标志物的比较研究
Tadashi Toyama,Takahiro Imaizumi,Takayuki Hamano et al.
Tadashi Toyama et al.
Background and hypothesis: The urinary albumin-to-creatinine ratio (UACR) is an established surrogate endpoint for kidney failure in chronic kidney disease (CKD). However, proteinuria remains widely used in routine clinic...
Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD [0.03%]
芬戈利尤单抗介导的T2DM合并CKD患者收缩压降低和尿白蛋白排量减少及其心血管获益关系的研究
Rajiv Agarwal,Ambarish Pandey,Scott D Solomon et al.
Rajiv Agarwal et al.
Background and hypothesis: Finerenone reduces cardiovascular events in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). The cardiovascular benefit emerges within months, before measurable kidney prote...